American Capital Advisory’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$451 Hold
3
﹤0.01% 975
2026
Q1
$278 Buy
3
+2
+200% +$201 ﹤0.01% 982
2025
Q4
$103 Buy
+1
New +$89 ﹤0.01% 996

Other funds holding GH

American Capital Advisory's GH Position: Q2 2026 in Review

American Capital Advisory held its Guardant Health (GH) position steady in Q2 2026 at 3 shares worth $451. The position accounts for ﹤0.01% of the portfolio, ranked #975.

American Capital Advisory first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • American Capital Advisory held 3 shares of Guardant Health worth $451 as of Q2 2026.
  • American Capital Advisory left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #975 holding.
  • American Capital Advisory first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.